CSIMarket
 

Bausch and Lomb Corp  (NYSE: BLCO)

Bausch And Lomb's

Competitiveness




 

BLCO Sales vs. its Competitors Q2 2026



Comparing the current results to its competitors, Bausch And Lomb reported Revenue increase in the 2 quarter 2026 by 9.08 % year on year.
The sales growth was above Bausch And Lomb's competitors' average revenue growth of 6.94 %, achieved in the same quarter.

List of BLCO Competitors





Revenue Growth Comparisons




Net Income Comparison


Bausch and Lomb Corp, despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 1.71 %

<<  BLCO Stock Performance Comparisons


Bausch And Lomb's Comment on Competition and Industry Peers


The company competes with larger firms that have greater financial, technical, and human resources. Key competitive factors include technological advancements, patents held, and new product introductions by competitors. The company also faces competition from generic, biosimilar, and other alternatives to its branded products, including those without patent or data exclusivity. Additional competitive challenges involve market acceptance, pricing, promotional effectiveness, reimbursement by government authorities and third-party payors, formulary inclusion, and supply chain considerations.



  

Overall company Market Share Q2 2026

With revenue growth of 9.08 % within Overall company, Bausch and Lomb Corp achieved improvement in market share, within Overall company to approximately 4.95 %.
<<  More on BLCO Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Bausch and Lomb Corp




Alcon inc
Share Performance



-2.10%
Over The Past 5 Days



Alcon inc
Profile

Alcon Inc's business model revolves around providing advanced eye care products and services, including pharmaceuticals, surgical equipment, and vision care solutions.

More about Alcon inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 34,982.100 mill. $ 12,997.000 mill. $ 1,156.000 mill.


The Cooper Companies Inc
Share Performance



-14.20%
This Year



The Cooper Companies Inc
Profile

The Cooper Companies Inc is a global medical device firm focused on manufacturing and distributing contact lenses and womens healthcare products. Its business model emphasizes innovation, strong distribution, strategic acquisitions, and partnerships to enhance market presence, targeting the specific needs of customers in eye care and womens health. Through research and development, they aim to improve customer lives while maximizing shareholder value.

More about The Cooper Companies Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 13,570.050 mill. $ 4,230.400 mill. $ 235.800 mill.


National Vision Holdings Inc
Share Performance



-3.68%
Over The Past 5 Days



National Vision Holdings Inc
Profile

National Vision Holdings Inc is a leading retailer of eyewear and optical products in the United States. The company operates a vertically integrated business model, which involves manufacturing, marketing, and distributing a wide range of eyewear products through its branded retail stores and third-party retail locations. National Vision Holdings Inc focuses on offering affordable and accessible vision care solutions to customers by leveraging its supply chain and retail network capabilities.

More about National Vision Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,349.194 mill. $ 2,033.426 mill. $ 50.286 mill.


Johnson and Johnson
Share Performance



+23.29%
This Quarter



Johnson and Johnson
Profile

Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.

More about Johnson and Johnson's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 671,588.723 mill. $ 97,929.000 mill. $ 21,037.000 mill.


Masimo Corp
Share Performance



+2.55%
This Quarter



Masimo Corp
Profile

Masimo Corp is a medical technology company that focuses on developing and manufacturing innovative monitoring devices for patient care. Their business model revolves around creating and selling advanced noninvasive monitoring solutions to healthcare providers worldwide. They also generate revenue through licensing agreements, providing maintenance and support services, and selling disposable products and accessories related to their monitoring devices.

More about Masimo Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 9,465.370 mill. $ 1,557.000 mill. $ 76.300 mill.

8 more competitors available

Sign in to see all competitors

Sources: Bausch and Lomb Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Bausch and Lomb Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.